AnaptysBio, Inc.
MX ˙ BMV ˙ US0327241065
SecurityMX:ANAB / AnaptysBio, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in ANAB / AnaptysBio, Inc.

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of AnaptysBio, Inc. (MX:ANAB). This represents 0.0 percent ownership of the company. In their previous filing dated 2025-07-29 , Vanguard Group Inc had reported owning 1,537,550 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-03-26 2026-03-26 13G/A 1,537,550 0 -100.00 0.00 -100.00
2025-07-29 2025-07-29 13G 1,517,325 1,537,550 1.33 5.23 5.87
2025-04-30 2025-04-30 13G/A 1,380,115 1,517,325 9.94 4.94 -4.82
2024-02-13 2024-02-13 13G/A 1,776,908 1,380,115 -22.33 5.19 -16.96
2023-02-09 2023-02-09 13G/A 1,842,683 1,776,908 -3.57 6.25 -6.30
2022-02-09 2022-02-09 13G/A 2,220,321 1,842,683 -17.01 6.67 -17.86
2021-02-10 2021-02-10 13G/A 2,194,661 2,220,321 1.17 8.12 0.50
2020-02-12 2020-02-12 13G/A 1,889,201 2,194,661 16.17 8.08 14.45
2019-02-11 2019-02-11 13G 1,889,201 7.06

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F ANAPTYSBIO COM 032724106 1,544,037 67,048 4.54 74,855 65.51 0.0011
2025-11-07 2025-09-30 13F ANAPTYSBIO COM 032724106 1,476,989 -60,561 -3.94 45,225 32.50 0.0007
2025-08-11 2025-06-30 13F ANAPTYSBIO COM 032724106 1,537,550 20,225 1.33 34,134 21.01 0.0006
2025-05-09 2025-03-31 13F ANAPTYSBIO COM 032724106 1,517,325 -326,415 -17.70 28,207 15.55 0.0005
2025-02-11 2024-12-31 13F ANAPTYSBIO COM 032724106 1,843,740 143,584 8.45 24,411 -57.14 0.0004
2024-11-13 2024-09-30 13F ANAPTYSBIO COM 032724106 1,700,156 275,750 19.36 56,955 59.56 0.0010
2024-08-13 2024-06-30 13F ANAPTYSBIO COM 032724106 1,424,406 70,403 5.20 35,696 17.06 0.0007
2024-05-10 2024-03-31 13F ANAPTYSBIO COM 032724106 1,354,003 -26,112 -1.89 30,492 3.15 0.0006
2024-03-11 2023-12-31 13F/A-1 ANAPTYSBIO COM 032724106 1,380,115 -322,666 -18.95 29,562 -3.33 0.0006
2024-02-14 2023-12-31 13F ANAPTYSBIO COM 032724106 1,380,115 -322,666 29,562 0.0006
2023-12-18 2023-09-30 13F/A-1 ANAPTYSBIO COM 032724106 1,702,781 -72,916 -4.11 30,582 -15.33 0.0008
2023-11-14 2023-09-30 13F ANAPTYSBIO COM 032724106 1,702,781 -72,916 30,582 0.0001
2023-08-14 2023-06-30 13F ANAPTYSBIO COM 032724106 1,775,697 -43,429 -2.39 36,118 -8.76 0.0009
2023-07-14 2023-03-31 13F/A-1 ANAPTYSBIO COM 032724106 1,819,126 42,218 2.38 39,584 -28.12 0.0010
2023-05-15 2023-03-31 13F ANAPTYSBIO COM 032724106 1,819,126 42,218 39,584 0.0010
2023-02-10 2022-12-31 13F ANAPTYSBIO COM 032724106 1,776,908 31,800 1.82 55,066 23.69 0.0015
2022-11-14 2022-09-30 13F ANAPTYSBIO COM 032724106 1,745,108 14,638 0.85 44,518 26.73 0.0013
2022-08-12 2022-06-30 13F ANAPTYSBIO COM 032724106 1,730,470 -96,844 -5.30 35,129 -22.29 0.0010
2022-05-13 2022-03-31 13F ANAPTYSBIO COM 032724106 1,827,314 -15,369 -0.83 45,208 -29.40 0.0011
2022-02-14 2021-12-31 13F ANAPTYSBIO COM 032724106 1,842,683 13,453 0.74 64,032 29.07 0.0015
2021-11-12 2021-09-30 13F ANAPTYSBIO COM 032724106 1,829,230 -54,911 -2.91 49,609 1.54 0.0012
2021-08-13 2021-06-30 13F ANAPTYSBIO COM 032724106 1,884,141 -440,118 -18.94 48,855 -2.46 0.0012
2021-05-14 2021-03-31 13F ANAPTYSBIO COM 032724106 2,324,259 103,938 4.68 50,089 4.93 0.0014
2021-02-12 2020-12-31 13F ANAPTYSBIO COM 032724106 2,220,321 156,244 7.57 47,737 56.80 0.0014
2020-11-16 2020-09-30 13F ANAPTYSBIO COM 032724106 2,064,077 -191,503 -8.49 30,445 -39.58 0.0010
2020-08-14 2020-06-30 13F ANAPTYSBIO COM 032724106 2,255,580 -90,634 -3.86 50,390 52.00 0.0018
2020-05-15 2020-03-31 13F ANAPTYSBIO COM 032724106 2,346,214 151,553 6.91 33,152 -7.04 0.0014
2020-02-14 2019-12-31 13F ANAPTYSBIO COM 032724106 2,194,661 -18,572 -0.84 35,664 -53.95 0.0012
2019-11-14 2019-09-30 13F ANAPTYSBIO COM 032724106 2,213,233 228,089 11.49 77,442 -30.86 0.0029
2019-08-14 2019-06-30 13F ANAPTYSBIO COM 032724106 1,985,144 65,527 3.41 112,001 -20.13 0.0042
2019-05-15 2019-03-31 13F ANAPTYSBIO COM 032724106 1,919,617 30,416 1.61 140,228 16.36 0.0055
2019-02-14 2018-12-31 13F ANAPTYSBIO COM 032724106 1,889,201 37,271 2.01 120,513 -34.78 0.0054
2018-12-13 2018-09-30 13F/A-2 ANAPTYSBIO COM 032724106 1,851,930 308,517 19.99 184,767 68.51 0.0072
2018-11-23 2018-09-30 13F/A-1 ANAPTYSBIO COM 032724106 1,851,930 0 184,767 0.0072
2018-11-14 2018-09-30 13F ANAPTYSBIO COM 032724106 1,851,930 308,517 184,767
2018-08-14 2018-06-30 13F ANAPTYSBIO COM 032724106 1,543,413 288,792 23.02 109,645 -16.03 0.0046
2018-05-15 2018-03-31 13F ANAPTYSBIO COM 032724106 1,254,621 344,051 37.78 130,580 42.38 0.0057
2018-02-14 2017-12-31 13F ANAPTYSBIO COM 032724106 910,570 484,584 113.76 91,713 516.02 0.0040
2017-11-14 2017-09-30 13F ANAPTYSBIO COM 032724106 425,986 219,955 106.76 14,888 201.93 0.0007
2017-08-24 2017-06-30 13F/A-1 ANAPTYSBIO COM 032724106 206,031 37,932 22.57 4,931 5.70 0.0002
2017-08-11 2017-06-30 13F ANAPTYSBIO COM 032724106 206,031 37,932 4,931
2017-05-12 2017-03-31 13F ANAPTYSBIO COM 032724106 168,099 168,099 4,665 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.